These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7781117)

  • 1. [Studies on the histological classification of proliferative disease of breast and its relation with breast carcinoma].
    Zhang J; Liu H; Liu B
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):43-5. PubMed ID: 7781117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The histology of mastopathy and cumulative ipsilateral breast cancer sequence].
    Prechtel K; Gehm O; Geiger G; Prechtel P
    Pathologe; 1994 Jun; 15(3):158-64. PubMed ID: 8072949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
    Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
    Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphology of dysplasia and small cancer of the breast].
    Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
    Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
    Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
    In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of interphasic NORs as a diagnostic parameter of atypical lesions of the female breast.
    Di Stefano D; Scucchi L; Limiti MR; Mingazzini PL; Marinozzi V
    Anticancer Res; 1996; 16(4A):1953-61. PubMed ID: 8712727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological study of radial sclerosing lesions].
    Zhang XL; Yang GZ; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):10-3. PubMed ID: 20388392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia.
    Whiffen A; El-Tamer M; Taback B; Feldman S; Joseph KA
    Ann Surg Oncol; 2011 Feb; 18(2):463-7. PubMed ID: 20878246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
    Jackman RJ; Nowels KW; Rodriguez-Soto J; Marzoni FA; Finkelstein SI; Shepard MJ
    Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
    Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
    Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
    Masood S
    Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions.
    Mariuzzi GM; Mariuzzi L; Mombello A; Santinelli A; Valli M; Rahal D; Thompson D; Bartels PH
    Pathol Res Pract; 1994 Nov; 190(11):1056-65. PubMed ID: 7746739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration of well differentiated small-cell duct carcinoma of the breast.
    Fiorella RM; Kragel PJ; Shariff A; Dubey S
    Diagn Cytopathol; 1997 Mar; 16(3):226-9. PubMed ID: 9099542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.